POSTN and hepatocellular carcinoma: In addition, small molecule inhibitors targeting the signaling pathways that drive POSTN expression, such as curcumol (Jia et al., 2020), inhibits HSC activation, and its potential to downregulate POSTN in HCC can be investigated.